Sreelakshmi24’s Blog

where life is all about learning

Archive for the ‘cryosave’ Category

Creator of “mini liver” & Cryo-Save Scientific director Prof. McGuckin to visit India

with one comment

020209-1537-profcolinmc1.jpgCryo-Save India today announced that their new Scientific Director Professor Colin McGuckin, will be visiting India between February 27 and March 3, 2009. Prof. McGuckin, who made a medical breakthrough in 2005 with the creation of the world’s first “mini liver” from umbilical cord blood, will share his plans on integrating new scientific technologies which may substantially speed up treatments for life-threatening illnesses, injuries and disabilities. Cryo-Save India, who has taken the initiative to organize the Professor’s visit, believes that this will act as an impetus for people in India to accept stem cell banking as a new form of health protection for the future.

During his visit, Prof. McGuckin will engage with regulatory authorities to share information that will shape future direction and progress in cord blood banking and advances in patient treatments. He will also talk about his latest discoveries in Regenerative Medicine, including his recent creation of the world’s first artificial pancreas, which may have important implications in diabetes.

Prof McGuckin, who has recently been appointed as Scientific Director for Cryo-Save, will be travelling to Bangalore, New Delhi and Mumbai.

Armed with 20 years of experience in stem cells, Professor McGuckin is an opinion leader who has been called upon by governments and hospitals around the world. He is also President of the Novus Sanguis Consortium, which brings together leading adult stem cell researchers and clinicians from across the world to work on specific diseases of the human condition, including heart disease, stroke, diabetes and organ degeneration.

Prof. Colin McGuckin Is Cryo-Save Group’s New Scientific Director

with one comment

Cryo-Save Group, Europe’s Largest Adult Stem Cell Banking Company announced the appointment of its new Scientific Director, Professor Colin McGuckin. In his new role, Professor McGuckin will be responsible for integrating new scientific technologies and keeping Cryo-Save’s storage services at the leading edge.

Professor McGuckin has made several advancements in stem cells including the creation of a “mini liver” from the umbilical cord blood, nervous tissues and blood vessels from cord blood cells as well as “pancreatic islets” – a major producer of insulin for treating diabetes amongst others.

Armed with 20 years of experience in stem cells, Professor McGuckin is an opinion leader who has been called upon by governments and hospitals around the world. He is also President of the Novus Sanguis Consortium, which brings together leading adult stem cell researchers and clinicians from across the world to work on specific diseases of the human condition, including heart disease, stroke, diabetes and organ degeneration.

Professor McGuckin stated, “My vocation is to treat patients with umbilical cord blood and I believe Cryo-Save, with their innovative and responsible program for storing cord blood will help achieve this goal faster, for more patients on an international scale.”

Rob Koremans, CEO, Cryo-Save said, “Prof. McGuckin’s recruitment is an auxiliary step in our efforts to put Cryo-Save at the forefront of the global stem cell market place. Gaining such tremendous scientific know how will help sustain financial security and contributions to patients”.


Cryo-Save India forays into the Western region

leave a comment »

Cryo-Save India, the 100% Indian subsidiary of Cryo-Save Group, announced their foray into the western region of the country by launching a full-fledged marketing set-up in Mumbai. The new office is part of their strategic plan for India and is envisioned to further strengthen the company’s position in the Indian market. To cater to parents growing need of providing bio-insurance to their offspring, Cryo-Save India has plans for a phased launch in key centres across the country. In Maharashtra, the city of Mumbai alone has 50,000 births per year and Pune has over 20,000 births every year in the Sec (Socio-Economic classification) A & A+ category. The company’s sales office is head quartered in Mumbai and their Maharashtra plans include representation in cities like Nagpur, Aurangabad, Pune, etc.

Cryo-Save India, with its corporate office in Bangalore, was recently set up with an investment of 1.8 Million Euros. Cryo-Save Group will scale up its investment to 2 million Euros within a year of its operation of the Indian subsidiary. The group company, Europe’s largest adult stem cell storage bank, has its operations in 37 countries across three continents. Cryo-Save India brings to the table a depth of expertise and experience in stem cell banking.

Cryo-Save India will be the only company in India with its unique offering of dual-storage system and this will be available for the first time in the country. They are also the only company that does automatic processing to avoid manual intervention and contamination. The company will be offering the collection and storage of ADULT stem cells derived from cord blood. The services will be available across all metros and other cities.

V.R. Chandramouli, Managing Director, Cryo-Save India, said, “We are very keen to extend our footprint to India specifically in the Western market as we see an immense market potential for adult stem cell banking or family banking in the Maharashtra region. A world-class stem cell banking service was the need of the hour for a huge market like India and Cryo-Save India will be offering this. We believe that the launch of the Indian operations has ushered in a new chapter in the quality of stem cell banking services offered.”

For more details on Cryo-Save India please visit http://www.cryo-save.com/india/index.html